technology

“Clinical trial design, cost, regulatory burden and recruitment are some of the challenges associated with clinical research,” said Victor J. Dzau, M.D., president, National Academy of Medicine and Research!America board member. Dzau joined other experts in basic science, clinical and translational research and patient advocacy to explore developments in clinical research during a Research!America Capitol Hill Briefing titled “Innovation Intersection” on June 12, 2017. “We must look at ways to leverage technology and utilize data sharing to make [clinical research] more efficient,” Dzau said. “And, of course, it’s important to shift towards looking at segments of the population, instead of...
Technology transfer, or the practice of transferring scientific findings from one organization, most notably universities, to another for further development, plays a pivotal role in the R&D ecosystem. It is the bridge that ensures knowledge cultivated through academic research reaches patients and other beneficiaries, and it is a critically important means of financing further science and technology at academic institutions in the U.S. and around the world. The Association of University Technology Managers (AUTM), a nonprofit organization with an international membership of more than 3,000 technology managers and business executives, has developed a project that not only highlights the...
Guest blog post by the American Chemical Society. How has the Super Bowl’€™s economy-driving market impact grown thanks to scientific research? Can a value be placed on innovation? What is the economic impact of science and technology research? What is the return on investment of research and development? These questions were addressed at the January 30, 2014, American Chemical Society Science & the Congress briefing, Measuring Economic Growth: R&D Investments , held on Capitol Hill. Moderated by the National Academies’€™ Stephen Merrill, PhD, panelist Steve Landefeld, PhD, of the Bureau of Economic Analysis spoke on how R&D numbers are now included in gross domestic product...
Dear Research Advocate: Research!America, in partnership with the American Society of Hematology, released a new poll on Tuesday, revealing strong feelings about the consequences of recent fiscal debacles. A majority (57%) of Americans, across party lines, believe that the government shutdown in October caused significant harm to programs like medical research, defense and education, programs that Americans value. It is not difficult to connect the dots between fiscal dysfunction and the future of our nation: More Americans than ever believe that our nation’€™s global leadership in science, technology and research will soon be a thing of the past,with 73% saying we will lose global...
A report this month by the McKinsey Global Institute ’€” the subject of a story on The Washington Post’€™s Wonkblog ’€” identified 12 ’€œdisruptive technologies’€ that could be transformative for the U.S. economy. Such a forecast necessitates some parameters, of course. The authors, led by MGI Director James Manyika, DPhil, restricted their survey to already-established technologies which could have impacts across industries with a high potential economic impact. And with any forecast, the results are hardly ironclad. But, as Wonkblog contributor Neil Irwin writes, the study ’€œrepresent[s] a serious effort by some smart people to quantify what appear to be some major forces shaping our...
New Poll Data Summary reveals concerns among Americans about medical progress even in tight fiscal environment Alexandria, Va. - January 9, 2013 - America Speaks , Volume 13, a compilation of public opinion polls commissioned by Research!America, features timely data about Americans’ views on issues related to biomedical and health research. A majority of Americans (72%) say the new Congress and the President should take action to expand medical research within the first 100 days of the 113 th Congress. Public support for increased government spending on medical research holds particular relevance as Congress considers whether to further delay, eliminate or permit “sequestration,” a budget...

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America